alopecia areata

— Disease Burden Could Worsen, Impacting Quality of Life, Experts Warn According to a recent retrospective cohort study, patients diagnosed with alopecia areata (AA) exhibited a greater prevalence of both autoimmune and psychiatric comorbidities at diagnosis. They were also found to be at an increased risk of developing new comorbidities after diagnosis. At diagnosis, 30.9% of patients with alopecia areata had psychiatric comorbidities compared to 26.8% of control subjects without alopecia